TORONTO–(BUSINESS WIRE)– Conavi TM Medical Inc. (www.conavi.com) is pleased to announce that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its NovasightTM Hybrid System. The system enables simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and Optical Coherence Tomography (OCT). IVUS or OCT are typically […]
Other News
Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Charing Cross International Symposium 2018
REDWOOD CITY, Calif., April 30, 2018 – Avinger, Inc. (AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that its next generation Pantheris® Lumivascular atherectomy system with extended nosecone was featured in a live case transmission at Charing Cross Symposium (CX) 2018 held in London, England. Charing Cross […]
Zynex Schedules 2018 First Quarter Earnings Release and Webcast
LONE TREE, Colo., May 1, 2018 /PRNewswire/ — Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2018 first quarter investor webcast on Tuesday, May […]
LuxCath to Showcase Its Breakthrough OmniView Light-Guided Ablation Catheter at HRS 2018
BOSTON–(BUSINESS WIRE)–LuxCath, LLC will showcase the next generation of its proprietary OmniView™ light-guided catheter ablation system at the 2018 Heart Rhythm Society (HRS) conference in Boston, May 9 to 12 at the Boston Convention Center. The OmniView light-guided ablation catheter is the only technology that can see into tissue during cardiac […]
Biomerics And ATL Technologies Acquire CRI Medical
SALT LAKE CITY and INDIANAPOLIS, April 30, 2018 /PRNewswire/ — Biomerics and ATL Technology, in a joint venture (Biomerics ATL, LLC), announced on Tuesday, April 24, 2018, that they have entered into an agreement under which together they will acquire Catheter Research Inc. (CRI)‘s assets in the Indianapolis and Costa Rica divisions. CRI is a manufacturer of interventional catheters, tube sets, and other […]
LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million
LONDON & SHANGHAI–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”) today announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, […]
Prospective Clinical Data on the FlowTriever System Confirms Excellent Results in the Treatment of Pulmonary Embolism
IRVINE, CALIFORNIA – April 27, 2018 – Inari Medical, Inc., announced today the presentation of results from its FlowTriever Pulmonary Embolectomy (“FLARE”) Clinical Study that evaluated the safety and effectiveness of the FlowTriever Retrieval/Aspiration System for the treatment of pulmonary embolism (“PE”). The results were presented by Thomas Tu, MD, […]
US Endovascular Enters Into An Exclusive Distribution Agreement with Lepu Medical – Expands Peripheral and AV Access Product Portfolio
EARTH CITY, MO. (PRWEB) APRIL 27, 2018 Guide Wires and Inflation Device Kits, will allow US Endovascular to further its goal of offering the highest quality peripheral endovascular devices at the lowest possible cost to AV Access Centers, OBL (Outpatient Based Labs) and Hospital Systems. This partnership will also allow Lepu […]
Teleflex Incorporated to Host Analyst & Investor Day on May 11, 2018
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, today announced the agenda for its 2018 Analyst & Investor Day, which will be held on Friday, May 11, 2018. A live webcast of the event presentations will begin at 9:00 a.m. ET. 2018 Analyst & Investor Day […]
AtriCure Reports First Quarter 2018 Financial Results
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2018 financial results. “We are pleased with our first quarter performance and meaningful progress toward completing enrollment in CONVERGE,” said Mike Carrel, President and Chief Executive Officer […]
Recent
CorVascular to Showcase DuplexABI™ Solution at SVU 2026 Annual Conference & Marketplace
VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNovaTM Transcatheter Tricuspid Valve Replacement System
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
Popular
- No commented posts yet